Localisation of neuroendocrine tumours of the upper gastrointestinal tract
- PMID: 8174983
- PMCID: PMC1374794
- DOI: 10.1136/gut.35.4.471
Localisation of neuroendocrine tumours of the upper gastrointestinal tract
Abstract
In order to localise neuroendocrine tumours of the foregut type (that is, of the stomach, duodenum, and pancreas), 18 patients were studied prospectively by endoscopic ultrasonography, computed tomography, transabdominal ultrasonography, magnetic resonance imaging, and somatostatin receptor scintigraphy. These 18 patients had a total of 25 primary tumour lesions which were verified histologically in tissue obtained by surgery or by ultrasound or endoscopy guided biopsy. Tumours were found in the stomach (n = 1), duodenum (n = 6), pancreas (n = 17), and liver (n = 1). Endoscopic ultrasonography had the highest sensitivity for tumour detection, followed by somatostatin receptor scintigraphy, computed tomography, transabdominal ultrasonography, and magnetic resonance imaging (88%, 52%, 36%, 32%, and 24% respectively). Endoscopic ultrasonography was especially sensitive in tumours smaller than 2 cm in diameter (88% v somatostatin receptor scintigraphy 35%; computed tomography 12%; transabdominal ultrasonography 6%; and magnetic resonance imaging 0%). Of 17 tumours located in the pancreas, endoscopic ultrasonography showed a sensitivity of 94% (somatostatin receptor scintigraphy 47%; computed tomography 47%; transabdominal ultrasonography 41%; and magnetic resonance imaging 29%). Of eight extrapancreatic tumours, six were identified by endoscopic ultrasonography, five by somatostatin receptor scintigraphy, and only one by computed tomography, transabdominal ultrasonography, and magnetic resonance imaging. One neuroendocrine tumour that was not detected by endoscopic ultrasonography was correctly identified by somatostatin receptor scintigraphy. Endoscopic ultrasound allowed correct determination of the tumour size and tumour spread into parapancreatic structures, especially the large vessels (T stage), in all 14 patients operated upon. The lymph node stage (N stage) was correctly determined in 10 of these 14 patients. In summary, endoscopic ultrasonography and somatostatin receptor scintigraphy were the most sensitive imaging methods for the localisation of these tumours and should be used as early diagnostic procedures to accurately stage neuroendocrine tumours of the foregut type.
Similar articles
-
Endosonography of neuroendocrine tumors of the stomach, duodenum, and pancreas.Ann N Y Acad Sci. 1994 Sep 15;733:425-36. doi: 10.1111/j.1749-6632.1994.tb17292.x. Ann N Y Acad Sci. 1994. PMID: 7978891 Review.
-
Endoscopic ultrasonography of neuroendocrine tumours.Digestion. 2000;62 Suppl 1:45-50. doi: 10.1159/000051855. Digestion. 2000. PMID: 10940687
-
Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.Gut. 1996 Oct;39(4):562-8. doi: 10.1136/gut.39.4.562. Gut. 1996. PMID: 8944566 Free PMC article.
-
Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S190-4. Ital J Gastroenterol Hepatol. 1999. PMID: 10604128 Clinical Trial.
-
Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S186-9. Ital J Gastroenterol Hepatol. 1999. PMID: 10604127 Review.
Cited by
-
Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.World J Gastroenterol. 2004 Dec 15;10(24):3628-33. doi: 10.3748/wjg.v10.i24.3628. World J Gastroenterol. 2004. PMID: 15534919 Free PMC article. Clinical Trial.
-
Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options.Dig Dis Sci. 1999 Jun;44(6):1148-55. doi: 10.1023/a:1026672022917. Dig Dis Sci. 1999. PMID: 10389687 Review.
-
Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.Ann Surg. 2004 Nov;240(5):757-73. doi: 10.1097/01.sla.0000143252.02142.3e. Ann Surg. 2004. PMID: 15492556 Free PMC article. Review.
-
Arterial vs pancreatic phase: which is the best choice in the evaluation of pancreatic endocrine tumours with multidetector computed tomography (MDCT)?Radiol Med. 2007 Oct;112(7):999-1012. doi: 10.1007/s11547-007-0201-1. Epub 2007 Oct 21. Radiol Med. 2007. PMID: 17952679 English, Italian.
-
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.Gut. 2005 Jun;54 Suppl 4(Suppl 4):iv1-16. doi: 10.1136/gut.2004.053314. Gut. 2005. PMID: 15888809 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical